|
|
|
Volumn 30, Issue 2 SUPPL. 1, 1993, Pages 36-40
|
|
Prediction and management of adverse events associated with the use of factor IX complex concentrates
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTIVATED PROTHROMBIN COMPLEX;
AUTOANTIBODY;
BLOOD CLOTTING FACTOR 8 INHIBITOR;
BLOOD CLOTTING FACTOR 9;
BLOOD CLOTTING FACTOR 9 COMPLEX;
BLOOD CLOTTING FACTOR 9 CONCENTRATE;
ACUTE HEART INFARCTION;
ALLERGIC REACTION;
BLEEDING;
DEEP VEIN THROMBOSIS;
DISSEMINATED INTRAVASCULAR CLOTTING;
DRUG RESPONSE;
HEADACHE;
HEMOPHILIA;
HEPATITIS C VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
LUNG EMBOLISM;
NOSE CONGESTION;
PRIORITY JOURNAL;
REVIEW;
THROMBOSIS;
VERTIGO;
VIRUS TRANSMISSION;
BLOOD COAGULATION DISORDERS;
FACTOR IX;
HUMAN;
MYOCARDIAL INFARCTION;
THROMBOSIS;
VIRUS DISEASES;
|
|
EID: 0027232227
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (31)
|
|
References (0)
|
